The increase in price target by Morgan Stanley suggests a positive outlook on Marsh & McLennan's stock, potentially leading to short-term price appreciation. The Equal-Weight rating indicates that the stock is expected to perform in line with the market or sector, but the raised target implies an analyst's confidence in the company's potential to reach higher valuation levels.